Amkor Pharma, Inc.
Records under this name other than patents Amkor Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Amkor Pharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,371,896 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Aug 1, 2023 · USPTO record | Term ended | Term ended Aug 1, 2023 | USPTO record |
| US 6,927,303 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Jun 19, 2023 · USPTO record | Term ended | Term ended Jun 19, 2023 | USPTO record |
| US 7,189,878 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Jun 19, 2023 · USPTO record | Term ended | Term ended Jun 19, 2023 | USPTO record |
| US 7,319,160 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Ended no later than Jun 19, 2023 · USPTO record | Term ended | Ended no later than Jun 19, 2023 | USPTO record |
| US 7,511,074 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Jun 19, 2023 · USPTO record | Term ended | Term ended Jun 19, 2023 | USPTO record |